Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Viridian Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- +17 vs. Q3 2021
- Shares held
- 23.3M
- +9.73M (+72.0%) vs. Q3 2021
- Total value
- $459.8M
- +$237.4M (+106.7%) vs. Q3 2021
- New holders
- 20
- 22 more added
- Sold out
- 3
- 6 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 1,879,412 | $37.2M | 1.35% | +1,075,286+133.7% | Added |
| VR Adviser, LLC | 1,852,919 | $36.6M | 5.01% | +1,833,424+9,404.6% | Added |
| Frazier Management LLC | 1,505,200 | $29.8M | 2.29% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,423,053 | $28.1M | 0.43% | +530.0% | Added |
| Deep Track Capital, LP | 1,336,690 | $26.4M | 1.95% | +1,336,690 | New |
| TCG Crossover Management, LLC | 1,314,000 | $26.0M | 12.16% | +1,314,000 | New |
| Vivo Capital, LLC | 1,300,000 | $25.7M | 1.55% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,278,261 | $25.3M | 0.54% | +1,278,261 | New |
| Paradigm Biocapital Advisors LP | 1,209,051 | $23.9M | 6.83% | +1,209,051 | New |
| Fairmount Funds Management LLC | 944,092 | $18.7M | 6.15% | 00.0% | Unchanged |
| Citadel Advisors LLC | 943,340 | $18.6M | 0.02% | +943,340 | New |
| Vanguard Group Inc | 925,676 | $18.3M | 0.00% | +463,764+100.4% | Added |
| Commodore Capital LP | 847,683 | $16.8M | 3.88% | +180,009+27.0% | Added |
| D. E. Shaw & Co., Inc. | 764,613 | $15.1M | 0.02% | +44,083+6.1% | Added |
| Ally Bridge Group (NY) LLC | 604,774 | $12.0M | 4.18% | −300,204−33.2% | Reduced |
| Franklin Resources Inc | 600,023 | $11.9M | 0.00% | +230.0% | Added |
| Ghost Tree Capital, LLC | 500,000 | $9.88M | 3.79% | +150,000+42.9% | Added |
| Point72 Asset Management, L.P. | 472,864 | $9.35M | 0.04% | −137,136−22.5% | Reduced |
| Millennium Management LLC | 462,390 | $9.14M | 0.01% | +301,045+186.6% | Added |
| Acuta Capital Partners, LLC | 318,000 | $6.29M | 2.64% | +182,193+134.2% | Added |
| Cormorant Asset Management, LP | 300,000 | $5.93M | 0.35% | −42,562−12.4% | Reduced |
| Kynam Capital Management, LP | 287,934 | $5.69M | 3.04% | +287,934 | New |
| Woodline Partners LP | 257,670 | $5.09M | 0.07% | +257,670 | New |
| Atlas Venture Advisors, Inc. | 209,505 | $4.14M | 0.58% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 201,678 | $3.99M | 0.00% | +140,428+229.3% | Added |
| Eversept Partners, LP | 194,589 | $3.85M | 0.32% | +34,589+21.6% | Added |
| BlackRock Inc. | 153,126 | $3.03M | 0.00% | +102,285+201.2% | Added |
| Silverarc Capital Management, LLC | 123,806 | $2.45M | 1.10% | +17,728+16.7% | Added |
| Walleye Capital LLC | 110,175 | $2.18M | 0.07% | +87,674+389.6% | Added |
| Pura Vida Investments, LLC | 104,860 | $2.07M | 0.22% | +46,764+80.5% | Added |
| Atlas Venture Life Science Advisors, LLC | 90,072 | $1.78M | 0.16% | +90,072 | New |
| Soleus Capital Management, L.P. | 90,000 | $1.78M | 0.24% | +90,000 | New |
| Marshall Wace, LLP | 88,405 | $1.75M | 0.00% | +88,405 | New |
| ExodusPoint Capital Management, LP | 76,757 | $1.52M | 0.02% | +76,757 | New |
| Endurant Capital Management LP | 67,450 | $1.33M | 0.36% | +67,450 | New |
| Polar Asset Management Partners Inc. | 59,700 | $1.18M | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 59,328 | $1.17M | 0.00% | +24,677+71.2% | Added |
| Driehaus Capital Management LLC | 50,000 | $989.0K | 0.01% | 00.0% | Unchanged |
| LMR Partners LLP | 41,400 | $818.0K | 0.01% | +7,892+23.6% | Added |
| State Street Corp | 34,041 | $673.0K | 0.00% | +10,200+42.8% | Added |
| Maven Securities LTD | 21,951 | $434.0K | 0.05% | −118,049−84.3% | Reduced |
| 683 Capital Management, LLC | 21,628 | $428.0K | 0.02% | +21,628 | New |
| Schonfeld Strategic Advisors LLC | 21,512 | $425.0K | 0.00% | −22,488−51.1% | Reduced |
| Atom Investors LP | 18,884 | $373.0K | 0.10% | +18,884 | New |
| Qube Research & Technologies Ltd | 17,000 | $336.0K | 0.00% | +17,000 | New |
| Citigroup Inc | 14,884 | $294.0K | 0.00% | +14,884 | New |
| Morgan Stanley | 13,695 | $271.0K | 0.00% | +3,773+38.0% | Added |
| JPMorgan Chase & Co | 13,033 | $258.0K | 0.00% | +13,033 | New |
| PDT Partners, LLC | 12,615 | $249.0K | 0.02% | +12,615 | New |
| Sender Co & Partners, Inc. | 12,216 | $242.0K | 0.15% | +12,216 | New |
| Bank of America Corp | 9,514 | $188.0K | 0.00% | +9,341+5,399.4% | Added |
| Wells Fargo & Company | 486 | $9.00K | 0.00% | +74+18.0% | Added |
| UBS Group AG | 13 | $0 | 0.00% | −1,430−99.1% | Reduced |
| GPS Wealth Strategies Group, LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1 | $0 | 0.00% | +1 | New |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,034−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |